Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study-Reference-Cited by-同舟云学术

Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study

Published:2020-04-20 Issue:1 Volume:29 Page:97-105
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Torres Harrys A.,Lok Anna S.,Suarez-Almazor Maria E.,Warneke Carla L.,Kaseb Ahmed,Miller Ethan,Sturgis Erich M.,Foreman Jessica T.,Angelidakis Georgios,Ahmed Sairah,Ferrajoli Alessandra,Samaniego Felipe,Hawk Ernest T.,Hwang Jessica P.

Funder

National Cancer Institute

MD Anderson Cancer Center Clinical Trials Support Resource

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-020-05456-3.pdf

Reference37 articles.

1. Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V (2017) The oncologic burden of hepatitis C virus infection: a clinical perspective. CA Cancer J Clin 67:411–431. https://doi.org/10.3322/caac.21403

2. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA (2016) Association between hepatitis C virus and head and neck cancers. J Natl Cancer Inst 108. https://doi.org/10.1093/jnci/djw035

3. Rangel JB, Thuler LCS, Pinto J (2018) Prevalence of hepatitis C virus infection and its impact on the prognosis of head and neck cancer patients. Oral Oncol 87:138–143. https://doi.org/10.1016/j.oraloncology.2018.10.024

4. Peffault de Latour R, Levy V, Asselah T, Marcellin P, Scieux C, Ades L, Traineau R, Devergie A, Ribaud P, Esperou H, Gluckman E, Valla D, Socie G (2004) Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 103:1618–1624. https://doi.org/10.1182/blood-2003-06-2145

5. Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO (2013) Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol 5:332–335. https://doi.org/10.4254/wjh.v5.i6.332